| Literature DB >> 35317753 |
Jiaming Lin1, Xiaojun Zhu1, Qinglian Tang1, Jinchang Lu1, Huaiyuan Xu1, Guohui Song1, Chuangzhong Deng1, Hao Wu1, Yufeng Huang1, Anfei Huang1, Yanyang Xu1, Hongmin Chen1, Jin Wang2.
Abstract
BACKGROUND: Minimally invasive separation surgery (MISS) is a safe and effective surgical technique, the current optimal treatment for spinal metastases. However, the learning curve for this technique has not been analyzed. This study aimed to define and analyze the surgical learning curve of MISS for the treatment of spinal metastases with small incision and freehand pedicle screw fixation.Entities:
Keywords: Bone metastases; Malignant tumor; Minimally invasive separation surgery (MISS); Myelopathy; Spinal metastases; Surgical learning curve
Mesh:
Year: 2022 PMID: 35317753 PMCID: PMC8939122 DOI: 10.1186/s12891-022-05191-2
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1A representative case: a 52-year-old man with L2 hepatic carcinoma metastasis. A-D The T2and T1-weighted sagittal (A and B) and axial (C and D) MRI images showed a destructive lesion involving L2 with high-grade ESCC (Grade 2). E–F Photographs showing the 5–6 cm incision in the midline for tumor debulking and spinal cord decompression (E). Another four small incisions (1.5-2 cm) were made for pedicle screws and rods implantation (F). G-H The sagittal (G) and axial (H) CT images demonstrated pedicle screws and rods position and PMMA after minimally invasive separation surgery (MISS)
Fig. 2The learning curve of minimally invasive separation surgery (MISS) as shown by operative time
Patients’ Demographic and Basic Clinical Data
| Age(mean ± SD) | 54.35 ± 10.48 | 53.98 ± 12.02 | 0.906 |
| Gender (%) | 0.544 | ||
| Female | 11(55%) | 24(57.1%) | |
| Male | 9(45%) | 18(42.9%) | |
| Number of spinal metastases (%) | 0.677 | ||
| multiple | 20(100%) | 41(97.6%) | |
| single | 0 | 1(2.4%) | |
| Surgical site (%) | 0.294 | ||
| Thoracic | 15(75%) | 27(64.3%) | |
| lumbar | 5(25%) | 15(35.7%) | |
| Coagulation dysfunction | |||
| Normal | 18(90%) | 42(100%) | 0.189 |
| Abnormal | 2(10%) | 0 | |
| Diabetes | |||
| Normal | 20(100%) | 39(92.9%) | 0.554 |
| Abnormal | 0 | 3(7.1%) |
SD standard deviation. The criteria for abnormal coagulation dysfunction were: prothrombin time (PT) has been increased by 3 s or activated partial thromboplastin time (APTT) increased by 10 s
Fig. 3The distribution of the surgical site in the vertebral body
The Distribution of Primary Tumor Types
| Primary tumor | Early phase group (%) | Later phase group (%) | |
|---|---|---|---|
| Breast | 2(10%) | 11(26.2%) | |
| Lung | 3(15%) | 9(21.4%) | |
| Kidney | 5(25%) | 2(4.8%) | |
| Liver | 1(5%) | 4(9.5%) | |
| Thyroid | 2(10%) | 1(2.4%) | |
| Myeloma | 2(10%) | 3(7.1%) | |
| Colorectal | 0 | 1(2.4%) | 0.318 |
| Unknow | 1(5%) | 3(7.1%) | |
| Prostate | 1(5%) | 0 | |
| Nasopharynx | 1(5%) | 2(4.8%) | |
| Uterus | 1(5%) | 1(2.4%) | |
| Other | 1(5%) | 5(11.9%) | |
| Total | 20(100%) | 42(100%) |
Preoperative Evaluation of Spinal Metastases
| Early phase group ( | Later phase group ( | ||
|---|---|---|---|
| Preoperative embolization (%) | 0.545 | ||
| yes | 1(5%) | 1(2.4%) | |
| no | 19(95%) | 41(97.6%) | |
| Preoperative Frankel grades (%) | 0.270 | ||
| A | 2(10%) | 1(2.4%) | |
| B | 0 | 0 | |
| C | 2(10%) | 12(28.6%) | |
| D | 10(50%) | 18(42.9%) | |
| E | 6(30%) | 11(26.2%) | |
| ESCC (%) | 0.651 | ||
| 1A | 0 | 1(2.4%) | |
| 1B | 2(10%) | 5(11.9%) | |
| 1C | 2(10%) | 5(11.9%) | |
| 2 | 10(50%) | 13(31.0%) | |
| 3 | 6(30%) | 18(42.9%) | |
| KPS (%) | 0.255 | ||
| ≥ 60 | 13(65%) | 22(52.4%) | |
| < 60 | 7(35%) | 20(47.6%) |
ESCC epidural spinal cord compression; KPS Karnofsky performance status
Surgical Data of Minimally Invasive Separation Surgery (MISS)
| Early phase group | Later phase group | ||
|---|---|---|---|
| Operative time (min) (mean ± SD) | 227.95 ± 80.69 | 189.02 ± 53.52 | 0.027 |
| Intraoperative blood loss (ml) (mean ± SD) | 686.50 ± 631.07 | 792.86 ± 532.89 | 0.533 |
| Massive blood loss (> 1000 ml) (%) | 4(20%) | 10(23.8%) | 0.505 |
| Postoperative drainage volume (ml) (mean ± SD) | 337.61 ± 253.51 | 471.88 ± 235.01 | 0.054 |
| Retention time of drainage tube (min) (mean ± SD) | 4.44 ± 1.67 | 4.88 ± 1.51 | 0.385 |
| Postoperative hospital stay (day) (mean ± SD) | 5.25 ± 2.27 | 4.93 ± 2.44 | 0.622 |
| Perioperative complications (%) | 1(5%) | 2(4.8%) | 0.696 |
SD standard deviation
The Improvement of Neurological Function after Operation
| Early phase group ( | Later phase group ( | ||
|---|---|---|---|
| Improvement of neurological functional status | 0.600 | ||
| improve | 6(30%) | 13(31.0%) | |
| stable | 14(70%) | 27(64.3%) | |
| worse | 0 | 2(4.8%) | |
| Frankel grades improvement | 0.827 | ||
| grade 0 | 14(70%) | 27(64.3%) | |
| grade 1 | 5(25%) | 12(28.6%) | |
| grade 2 | 1(5%) | 1(2.4%) |